Ineffective immune control of EBV may cause exacerbation

A forum to discuss research on the origins of MS and its development.

Ineffective immune control of EBV may cause exacerbation

Postby frodo » Thu Aug 03, 2017 1:48 am

"Ineffective immune control of EBV may cause exacerbation". That is the conclusion of this study, in which they say that normal CD8+ T-cells are able to kill EBV-infected B-cells, but in MS patients this control system is not working.

Programmed death 1 is highly expressed on CD8+CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to EBV.

https://www.ncbi.nlm.nih.gov/pubmed/28767147

Abstract:

In this study, we have investigated the response of a subpopulation of effector CD8+ T cells to EBV in 36 healthy donors and in 35 pwMS in active and inactive disease. We have measured the expression of markers of degranulation, the release of cytokines, cytotoxicity and the regulation of effector functions by inhibitory receptors, such as programmed death-1 (PD-1) and human inhibitor receptor Ig-like transcript 2 (ILT2).

We demonstrate that polyfunctional cytotoxic CD8+CD57+ T cells are able to kill EBV-infected cells in healthy donors. In contrast, an anergic exhaustion-like phenotype of CD8+CD57+ T cells with high expression of PD-1 was observed in inactive pwMS compared with active pwMS or healthy donors.

Detection of CD8+CD57+ T cells in meningeal inflammatory infiltrates from post-mortem MS tissue confirmed the association of this cell phenotype with the disease pathological process. The overall results suggest that ineffective immune control of EBV in pwMS during remission may be one factor preceding and enabling the reactivation of the virus in the CNS and may cause exacerbation of the disease.
User avatar
frodo
Family Elder
 
Posts: 934
Joined: Wed Dec 02, 2009 3:00 pm

Advertisement

Return to MS Etiology and Pathogenesis

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service